|
HS Code |
875530 |
| Chemical Name | Mibolerone |
| Synonyms | Cheque Drops, Matenon |
| Molecular Formula | C20H30O2 |
| Molar Mass | 302.45 g/mol |
| Drug Class | Anabolic-androgenic steroid (AAS) |
| Route Of Administration | Oral |
| Half Life | 4 hours |
| Legal Status | Controlled substance in many countries |
| Primary Use | Veterinary, estrus suppression in female dogs |
| Cas Number | 3704-09-4 |
As an accredited Mibolerone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for Mibolerone typically features a 1-gram amber glass vial with a secure screw cap, labeled with product details and safety information. |
| Shipping | Mibolerone is shipped in compliance with all relevant regulations for hazardous chemicals. It is securely packaged in leak-proof, tamper-evident containers, labeled according to international safety standards. During transit, temperature and humidity are monitored to ensure product integrity. Shipping is available through certified carriers with full tracking and documentation provided. |
| Storage | Mibolerone should be stored in a tightly closed container, away from light and moisture, at a controlled room temperature (between 20°C and 25°C or 68°F and 77°F). It must be kept out of reach of unauthorized persons and incompatible substances. Ensure proper labeling and follow standard laboratory procedures for handling and storage of potent, controlled substances. |
Applications of Mibolerone in Industrial ManufacturingMibolerone has established uses in specific regulated segments of the chemical and pharmaceutical industries. As the actual manufacturer, we focus on precisely defined industrial applications with strict compliance requirements, controlled processing methods, and technical-grade formulation parameters. Below, we outline the main sectors where this material is integrated as a functional chemical raw material. 1. Veterinary Pharmaceutical Hormone PreparationVeterinary hormone formulations utilize mibolerone as a synthetic androgenic agent, principally for reproductive cycle management in the care and breeding of canines. Industrial processing of veterinary pharmaceuticals requires strict adherence to pharmacopoeial monographs and veterinary regulations regarding hormone drug manufacturing. Mibolerone enters the ingredient weighing and granulation phase under containment conditions, followed by blending, compaction, and tablet pressing. Formulators determine the addition ratio based on species, target animal weights, and local dose limits, with accurate process control mandatory at every step. The finished goods include prescription-only veterinary medications under licensed brands for professional use. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Research and Development Reference StandardsAnalytical laboratories and pharmaceutical R&D divisions use mibolerone as a quantitative reference standard for instrument calibration in hormone analysis and pharmacokinetic research. Only highly purified industrial raw material is accepted in these settings, conforming to chemical reference substance protocols. Addition ratios depend on the specific validation study or assay being performed, and material introduction occurs during sample preparation or analytical method development. End products are not commercialized, but accurate calibration supports regulatory drug dossier submissions and bioanalytical method validation for subsequent product development pipelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Bulk Active Pharmaceutical Ingredient for Licensed ProcessingContract manufacturing organizations (CMOs) and licensed API formulators source mibolerone as an active pharmaceutical ingredient exclusively for legal veterinary drug production under national regulatory frameworks. The raw material enters at the upstream stage of pharmaceutical batch synthesis, after which it undergoes micronization, quality-controlled documentation, and intermediate blending. Strict process segregation and documented chain-of-custody are required to prevent cross-contamination. Tightly controlled dosage ranges reflect both pharmacological requirements and statutory limitations in registered APIs. The resulting intermediate and bulk forms are supplied only to downstream pharmaceutical processing plants holding the necessary licenses for finishing dosage forms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Stable Isotope Internal Standard ProductionChemical synthesis facilities and specialty chemical laboratories employ mibolerone as a precursor or base molecule for the design of stable isotope-labeled standards utilized in clinical and veterinary diagnostic assays. Stringent chemical purity and isotopic integrity requirements drive raw material selection. The compound is introduced at the initial synthetic stage for isotope exchange or labeling, followed by multi-step purification using crystallization and chromatography. Isotopic content and residual non-labeled fractions are confirmed by specialized QC equipment. Output is distributed to regulated test kit manufacturers and research laboratories for use as internal standards in hormone measurement panels, supporting regulatory and research-based applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Mibolerone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Mibolerone stands out in our product lineup because of its defined characteristics and technical clarity. As the manufacturer, we focus on every detail from sourcing to synthesis, and each batch meets the standards our customers have grown to expect. Our Mibolerone, made under strict laboratory controls, supports research and reference work in fields where molecular accuracy and batch replicability make all the difference.
Chemically known as 7α,17α-dimethyl-19-nortestosterone, Mibolerone belongs to the class of synthetic anabolic-androgenic steroids. Over decades of handling specialty chemicals, I’ve learned that precise production steps separate a good product from one that leaves researchers double-checking their results. We use a targeted crystallization process, combined with repeated purification, to lock in the specified molecular profile. Customers notice the difference in stability and the ability to get reproducible results across different trials.
Mibolerone arrives as a fine crystalline powder with a consistent off-white coloration. Particle fineness and moisture levels remain under constant surveillance throughout manufacturing—critical for preparing lab solutions and reference materials. Rigorous internal assays confirm chemical purity, always exceeding 98%, often reaching higher. This thorough approach reduces variables in bioassay work and analytical chemistry applications. It’s not about offering the highest number on a certificate; it’s about giving a product that won’t complicate your protocol with hidden contaminants.
Every batch we release comes from controlled synthesis runs, documented from raw input to final sealing. Oversight includes calibrated instrumentation, traceable solvents, and tight atmosphere control during key steps like condensation and methylation. Working directly on the synthesis means I see where small process deviations might creep in; I don’t accept them. We store reference samples from each batch and compare their spectral signatures regularly, aiming for ongoing consistency year after year.
End users often ask how our Mibolerone stands out from alternatives in an ever-demanding regulatory climate. I point to retained documentation for each batch, easily traceable back to the raw materials and every handling step. I’ve seen cases where researchers using uncontrolled sources encountered unexplained outliers or failed replications—usually after a supplier shortcut in quality checks. Over the years, we’ve invested in real-time documentation systems that not only meet, but sometimes exceed, regional chemical recordkeeping regulations. Our institutional partners know that if a question arises—days or years after delivery—we can trace the answer without delay.
Most specialists buying Mibolerone from us work in the fields of biomedical research, veterinary science, analytical chemistry, or forensic analysis. After decades of hands-on interaction with end users, I know researchers aren’t just ordering catalog numbers—they want reliability for their cell culture controls or analytical markers. In hormone receptor studies, the precise androgenic profile of Mibolerone helps distinguish response pathways that would get muddied with less specific substitutes.
We’ve seen Mibolerone applied in receptor binding assays, molecular pathway exploration, and laboratory screening toolkits for veterinary drug testing. Because of its unique dual methylation at the 7α and 17α positions, the compound resists rapid breakdown in enzymatic systems—a feature that often sets it apart for in vitro assays or extended timepoint measurements. Our partners in animal research value the stability, as it cuts down on dosing variation and allows for sharper endpoint interpretation.
The compound also provides a reference point in pharmaceutical development, particularly for benchmarking the activity of new androgen synthesis candidates or antagonists. Synthetic chemists and analytical labs rely on the reproducibility and predictable behavior—attributes directly tied to disciplined manufacturing, not a fluke of a single lucky batch.
Experience has taught me that fastidious attention early in the process solves many problems long before a batch is filled or shipped. As a manufacturer, I can pinpoint how each piece of equipment calibration, pressure regulation, or chromatographic check feeds into the quality loop. We never cut corners on raw materials. Our methylation agents and precursor testosterone analogues are selected for minimal side-reactivity and tracked throughout the process by lot and source.
Each lot runs through a battery of analytical tests—thin layer chromatography, high performance liquid chromatography, and nuclear magnetic resonance validation—before release. I’ve spent long evenings going over chromatograms, making sure the main signal reflects not just concentration, but true compound identity without ambiguous shadows or secondary peaks. Only after all results match benchmarks will material advance for cGMP-compliant packaging.
I train our technicians to spot any anomaly, not to assume every batch will go smoothly because the last one did. This mindset prevents product drift—a risk with high-sensitivity chemicals like Mibolerone. If a routine observation suggests even a trace impurity, that batch comes off the line and we start over.
Our packaging department handles Mibolerone in dedicated containment zones. The product fills glass or high-density polyethylene containers under nitrogen to prevent oxidation or moisture uptake. Seals carry tamper-evident features; each vessel leaves our facility with full batch and lot tracking numbers, traced to synthesis logs kept under lock. This system reassures users who might need complete documentation for audits or regulatory filings.
We label every unit with clear concentration and batch details. Hazard and handling advice reflects the latest evidence and practical know-how. Our documentation team updates the safety literature with each regulatory or toxicological review, so front-line lab staff work from current risk data.
Our logistics partners follow protocols we’ve set, too—temperature controlled if needed and tracked so any incident is flagged before materials arrive. We’ve learned over the years that even robust chemicals can lose stability at boundaries like customs warehouses or during long transit, so the transport chain gets almost as much scrutiny as the batch itself.
Customers often compare Mibolerone with conventional testosterone derivatives or veterinary-focused anabolic agents. While structurally related, Mibolerone’s dual methyl groups at the 7α and 17α positions block common metabolic breakdown routes. This property gives it sharper bioactivity and longer analytical detectability in biological matrices. In research, that translates to greater predictability across dosing regimens and test endpoints.
Unlike some analogues, Mibolerone maintains a strong receptor affinity even at low application concentrations. Scientists working with receptor binding assays or tissue response models detect clear outputs with smaller input masses. We’ve watched analytical clients develop new calibration curves because our material stays stable, letting them rely on long-lived standards without drifting over a project’s span—something competitors’ less-refined products rarely match.
A key point in manufacturing: many alternatives carry byproducts or residual solvents from inferior synthesis methods. Years of field feedback confirmed this—labs switching from other suppliers noticed noise in their data vanishing after moving to our material. It’s not marketing hyperbole; the day-to-day difference often starts with an analyst quietly confirming that the sample solution stays clear, batches after batch.
Managing a high-standard synthesis pipeline brings constant challenges. Unexpected changes in upstream chemical markets, evolving compliance demands, and the need to maintain both quality and scale keep us alert. We face shifting regulatory frameworks from country to country, and the only way through remains full transparency with both documentation and technical adaptation.
Recently, stricter environmental monitoring protocols forced us to reevaluate waste handling. Instead of sticking to old methods, we developed solvent recovery and in-house neutralization procedures, cutting down our waste and boosting cost control—real solutions that help us stay competitive. We keep dialogue open with both our research partners and the communities around us, sharing emission plans and taking feedback seriously. I’ve learned from years of oversight that open reporting doesn’t just satisfy authorities—it builds trust and strengthens our role in the supply chain.
Within our plant, we’ve committed to regular technical retraining and process audits. Senior staff monitor each synthesis phase, checking ingredient identity, reaction temperatures, and output spectra before passing on control to the next station. Digital logs keep an unbroken record, but the real value remains in the pairs of experienced eyes following the process from start to finish.
On the customer side, dialogue with technical support teams helps us track changing requirements. If a new analytical protocol emerges or a lab faces an unexpected interference in their data, we offer tailored guidance, referencing both internal documentation and years of batch notes. We believe that working with, not just for, our partners delivers better results. Even for rare application challenges, we pull teams together to replicate conditions in-house, troubleshooting live—because we've seen too many good projects slow down from untested off-the-shelf compounds.
With all performance chemicals, specifically in the anabolic agent category, the regulatory context tightens each year. We operate within legal mandates, submitting product testing data and participating in disclosure programs. Our documentation room holds registration filings from multiple regions, and we keep updated on changes affecting research and commercial use.
From the manufacturer’s standpoint, unchecked shortcuts cause costly failures down the line—both for compliance and for customer outcomes. So, we continually invest in analytical hardware upgrades, more robust serialization, and broader staff training. I encounter questions from new clients who wonder if the extra steps affect price. Experience tells me that ‘cheap’ product holds hidden risks, from uncertain performance to compliance exposure, and thorough manufacturing costs less in the end.
Supply chain security forms a growing part of our Mibolerone approach. We verify the origin of each precursor and maintain close oversight during international transit. Electronic certificates travel with each order, meeting traceability demands not just from science, but also customs and border authorities. This clarity means research partners can plan long term, without interruption.
Chemical manufacturing rewards those who build relationships founded on verification, repeatability, and candor. The scientific community, from university researchers to analytical service providers, trusts us with critical experiments and calibration sets because we establish two-way communication before and after sale. If an order needs custom dosing or specialized documentation for import review, we stand ready with both technical expertise and administrative support.
Direct manufacturing also means we own every output—no outsourcing, no ambiguous storage, and no judicious blending to meet a minimum assay. Every container comes from original synthesis, not a mixed remnant. I’ve spent years reviewing international recalls and supply chain failures linked to lost production controls; that isn’t our path. We show our batch histories and performance records to auditors, knowing the process will stand up in a competitive, regulated world.
Customers return for new projects or reference refills because of this stable foundation. I value each bit of feedback, whether about product clarity, bottling experience, or technical documentation. That input shapes future investments, both technical and human, making our Mibolerone better batch after batch.
Years spent refining Mibolerone’s synthesis have proven that in specialty chemical supply, excellence comes from consistency, transparency, and end-to-end control. Every adjustment, every technical improvement, and every interaction with end users brings new insights—helping us meet tomorrow’s scientific challenges with stronger products and deeper trust. Our method isn’t static. We seek regular input, welcome technical challenges, and adapt our process based on real-world outcomes.
By keeping process quality and customer communication at the heart of our practice, we ensure that each gram of Mibolerone upholds the accuracy, safety, and reproducibility that impactful science demands. Labs depend on precise materials to push boundaries; we give them a reliable platform to do so, today and into the future.